111 Country Club Dr, Incline Village, NV 89451
9.5 CME both days, 4 CME Friday, 5.5 CME Saturday. Please contact Johanna Bell for questions at bellj@med.unr.edu.
Sponsored by: Renown Health
Our conference will educate healthcare professionals on the most recent updates and developments around multiple solid tumor disease sites, exciting radiopharmaceutical therapies and cancer treatment options, as well as cancer wellness, lifestyle strategies, and survivorship.
Following participation in this course, participants should be able to:
Medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists, internal medicine and primary care physicians, physician assistants, nurse practitioners, and other healthcare professionals that work in the oncology setting, as well as UNR medical students and Renown residents.
This is an in-person CME event.
For information, please call (775) 784-1451 or bellj@med.unr.edu.
Registration closes April 20, 2026. After April 21, 2026, please contact Johanna Bell at bellj@med.unr.edu to inquire if late registration opportunities are available.
Cancellations received by April 1, 2026 will receive a full refund less a $25 cancellation fee. Cancellations after April 1, 2026 are non-refundable.
This program is supported by Renown Health.
The contents are those of the author(s) and do not necessarily represent the official views of Renown Health.
| Time | Event |
|---|---|
| 12:30 - 12:45 p.m. | Welcome and Introduction Suchit Patel, M.D., Ph.D. |
| 12:45 - 1:15 p.m. | Roles for Radioligand Therapy in Prostate Cancer Neal Taunk, M.D., MSCTS |
| 1:15 - 2:00 p.m. | Establishing a Radioligand Therapy Program Large Regional Cancer Centers Nichole M. Maughan, Ph.D., MS |
| 2:00 - 2:45 p.m. | Emerging Radioligand Isotopes, Alpha Particle Therapy, and Trials Freddy Escorcia, M.D., Ph.D. |
| 2:45 - 3:15 p.m. | Break and Exhibits |
| 3:15 - 3:45 p.m. | Radioligand Developments in Small Cell Lung Cancer Abdul Rafeh Naqash, M.D. |
| 3:45 - 4:30 p.m. | Updates on Radioligand in Neuroendocrine Tumors Robert A. Ramirez, D.O. |
| 4:30 - 5:00 p.m. | Closing Remarks Nicholas Manguso, M.D. |
| 5:00 - 6:00 p.m. | Welcome Reception and Poster Session |
| Time | Event |
|---|---|
| 6:30 - 7:30 a.m. | Evoke Warriors Boot Camp Mena Spodobalski, Certified Personal Trainer Evoke Fitness |
| 8:00 - 8:45 a.m. | Breakfast and Product Theater |
| 8:45 - 9:00 a.m. | Welcome and Introduction |
| 9:00 - 9:45 a.m. | The Gut Microbiome and Cancer Risk Urvi Shah, M.D. |
| 9:45 - 10:30 a.m. | Cancer Rehabilitation and Exercise Oncology Arash Asher, M.D. |
| 10:30 - 10:45 a.m. | Break and Exhibits |
| 10:45 - 11:30 a.m. | Lifestyle Medicine for Cancer Risk Reduction Amy Comander, M.D. |
| 11:30 a.m. - 12:00 p.m. | Renown Wellness Program Updates Madeline Hardacre, M.D. |
| 12:00 - 1:00 p.m. | Lunch |
| 1:00 - 2:15 p.m. | Sexual Health/Wellness in Cancer Patients Nick Hauser, M.D. and Jennifer Cross M.A. |
| 2:15 - 3:00 p.m. | Renown Clinical Research Kristen Gurnea, MPH and Katie Buckley, MHA, CCRC |
| 3:00 - 3:15 p.m. | Break and Exhibits |
| 3:15 - 3:45 p.m. | PCI Updates and Closing Remarks Max Coppes, M.D., PhD, MBA, and Kate Ward PharmD, BCPS |
Hotel Lake Tahoe Hotel Resort, Spa & Casino | Hyatt Regency Lake Tahoe
Reduced room rate available on Friday, May 1 and Saturday, May 2, 2026. Rooms must be booked before Friday, April 3, 2026, to be eligible for the reduced rate. Rooms subject to being sold out before April 3, 2026.
Reservation Phone Number 775-886-6602
Group code: G-RN05
Last Day to Make Room Reservation Date: Friday, April 3, 2026
Payment must be recieved by April 15, 2026
For additional information, please contact Johanna Bell.
The receipt of this registration form is a commitment to the exhibit/sponsor. Cancellations will not be refunded except in extenuating circumstances; in which case, a request must be made in writing and reviewed by the conference planning committee. Cancellations will be refunded less a $75 processing fee.
As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine, must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.
Urvi Shah. M.D.: Advisory Board: Janssen, Sanofi, Grant/Research Support: Janssen, BMS, Sabinsa, M and M labs
Abdul Rafeh Naqash, M.D.: Advisory Board: Foundation Med, Astellas, NGM Biosciences; Natera, Regeneron, GE Health; Grant/Research Support : Funding to Institution for Trials he is PI on: Loxo@Lilly, Surface Oncology, ADC Therapeutics, IGM Biosciences, EMD Serono, Aravive, Nikang Therapeutics, Inspirna, Exelexis, Revolution Medicine, Jacobio, Pionyr, Jazz Pharmaceuticals, NGM Biopharmaceuticals, Immunocore, Phanes Therapeutics, Kymera Therapeutics, Dren Bio, Marengo Therapeutics.SWOG Hope Foundation; Conquer Cancer; Consultant: JCO Precision Oncology; Other Financial Benefit: Educational Content: BinayTara Foundation, Foundation Med, Medlive
Neil Taunk, M.D.: Grant/Research Support: Novartis, RayzeBio, Varian Medical Systems; Consultant: Eli Lilly, Varian Medical Systems, Boston Scientific, Novartis
All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada, Reno School of Medicine and Renown Health. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.
The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nevada, Reno School of Medicine approves this program for 9.5 hours of nursing continuing education credit. Nevada State Board of Nursing provider number 120894-1.
The University of Nevada, Reno School of Medicine is a provider of continuing education credit through the Nevada State Board of Pharmacy. This program is approved for 9.5 hours of continuing education credit for pharmacists.